491 related articles for article (PubMed ID: 20603314)
1. B cell depletion reduces the development of atherosclerosis in mice.
Ait-Oufella H; Herbin O; Bouaziz JD; Binder CJ; Uyttenhove C; Laurans L; Taleb S; Van Vré E; Esposito B; Vilar J; Sirvent J; Van Snick J; Tedgui A; Tedder TF; Mallat Z
J Exp Med; 2010 Aug; 207(8):1579-87. PubMed ID: 20603314
[TBL] [Abstract][Full Text] [Related]
2. B cell-targeted therapy with anti-CD20 monoclonal antibody in a mouse model of Graves' hyperthyroidism.
Ueki I; Abiru N; Kobayashi M; Nakahara M; Ichikawa T; Eguchi K; Nagayama Y
Clin Exp Immunol; 2011 Mar; 163(3):309-17. PubMed ID: 21235532
[TBL] [Abstract][Full Text] [Related]
3. CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell-Mediated CD4 T Cell Responses.
Wong KY; Baron R; Seldon TA; Jones ML; Rice AM; Munster DJ
J Immunol; 2018 May; 200(10):3383-3396. PubMed ID: 29643191
[TBL] [Abstract][Full Text] [Related]
4. Maternal immunization programs postnatal immune responses and reduces atherosclerosis in offspring.
Yamashita T; Freigang S; Eberle C; Pattison J; Gupta S; Napoli C; Palinski W
Circ Res; 2006 Sep; 99(7):e51-64. PubMed ID: 16946133
[TBL] [Abstract][Full Text] [Related]
5. Auto-Antibody Production During Experimental Atherosclerosis in
Hutchinson MA; Park HS; Zanotti KJ; Alvarez-Gonzalez J; Zhang J; Zhang L; Telljohann R; Wang M; Lakatta EG; Gearhart PJ; Maul RW
Front Immunol; 2021; 12():695220. PubMed ID: 34305930
[TBL] [Abstract][Full Text] [Related]
6. Immunization with malondialdehyde-modified low-density lipoprotein (LDL) reduces atherosclerosis in LDL receptor-deficient mice challenged with Porphyromonas gingivalis.
Turunen SP; Kummu O; Wang C; Harila K; Mattila R; Sahlman M; Pussinen PJ; Hörkkö S
Innate Immun; 2015 May; 21(4):370-85. PubMed ID: 25134521
[TBL] [Abstract][Full Text] [Related]
7. B-Cell Depletion Promotes Aortic Infiltration of Immunosuppressive Cells and Is Protective of Experimental Aortic Aneurysm.
Schaheen B; Downs EA; Serbulea V; Almenara CC; Spinosa M; Su G; Zhao Y; Srikakulapu P; Butts C; McNamara CA; Leitinger N; Upchurch GR; Meher AK; Ailawadi G
Arterioscler Thromb Vasc Biol; 2016 Nov; 36(11):2191-2202. PubMed ID: 27634836
[TBL] [Abstract][Full Text] [Related]
8. Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE-/- mice.
Cesena FH; Dimayuga PC; Yano J; Zhao X; Kirzner J; Zhou J; Chan LF; Lio WM; Cercek B; Shah PK; Chyu KY
Atherosclerosis; 2012 Jan; 220(1):59-65. PubMed ID: 22062590
[TBL] [Abstract][Full Text] [Related]
9. The B cell in atherosclerosis: teaming up with the bad guys?
Nilsson J; Fredrikson GN
Clin Chem; 2010 Dec; 56(12):1789-91. PubMed ID: 20876772
[No Abstract] [Full Text] [Related]
10. Low-Density Lipoprotein-Reactive T Cells Regulate Plasma Cholesterol Levels and Development of Atherosclerosis in Humanized Hypercholesterolemic Mice.
Gisterå A; Klement ML; Polyzos KA; Mailer RKW; Duhlin A; Karlsson MCI; Ketelhuth DFJ; Hansson GK
Circulation; 2018 Nov; 138(22):2513-2526. PubMed ID: 29997115
[TBL] [Abstract][Full Text] [Related]
11. B-1b Cells Secrete Atheroprotective IgM and Attenuate Atherosclerosis.
Rosenfeld SM; Perry HM; Gonen A; Prohaska TA; Srikakulapu P; Grewal S; Das D; McSkimming C; Taylor AM; Tsimikas S; Bender TP; Witztum JL; McNamara CA
Circ Res; 2015 Jul; 117(3):e28-39. PubMed ID: 26082558
[TBL] [Abstract][Full Text] [Related]
12. The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis.
van Leeuwen M; Damoiseaux J; Duijvestijn A; Tervaert JW
Autoimmun Rev; 2009 Sep; 9(1):53-7. PubMed ID: 19285155
[TBL] [Abstract][Full Text] [Related]
13. Anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE and APOECD40L mice.
Smook ML; van Leeuwen M; Heeringa P; Damoiseaux JG; Theunissen R; Daemen MJ; Lutgens E; Tervaert JW
Clin Exp Immunol; 2008 Nov; 154(2):264-9. PubMed ID: 18778362
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin M is required for protection against atherosclerosis in low-density lipoprotein receptor-deficient mice.
Lewis MJ; Malik TH; Ehrenstein MR; Boyle JJ; Botto M; Haskard DO
Circulation; 2009 Aug; 120(5):417-26. PubMed ID: 19620499
[TBL] [Abstract][Full Text] [Related]
15. An unexpected intriguing effect of Toll-like receptor regulator RP105 (CD180) on atherosclerosis formation with alterations on B-cell activation.
Karper JC; de Jager SC; Ewing MM; de Vries MR; Bot I; van Santbrink PJ; Redeker A; Mallat Z; Binder CJ; Arens R; Jukema JW; Kuiper J; Quax PH
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2810-7. PubMed ID: 24115036
[TBL] [Abstract][Full Text] [Related]
16. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis.
Zhou X; Robertson AK; Rudling M; Parini P; Hansson GK
Circ Res; 2005 Mar; 96(4):427-34. PubMed ID: 15662027
[TBL] [Abstract][Full Text] [Related]
17. Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.
van Puijvelde GH; Hauer AD; de Vos P; van den Heuvel R; van Herwijnen MJ; van der Zee R; van Eden W; van Berkel TJ; Kuiper J
Circulation; 2006 Oct; 114(18):1968-76. PubMed ID: 17060383
[TBL] [Abstract][Full Text] [Related]
18. A functional role for inducible costimulator (ICOS) in atherosclerosis.
Afek A; Harats D; Roth A; Keren G; George J
Atherosclerosis; 2005 Nov; 183(1):57-63. PubMed ID: 15941568
[TBL] [Abstract][Full Text] [Related]
19. Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain Gene.
Centa M; Gruber S; Nilsson D; Polyzos KA; Johansson DK; Hansson GK; Ketelhuth DF; Binder CJ; Malin S
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):25-36. PubMed ID: 26564818
[TBL] [Abstract][Full Text] [Related]
20. The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-/- mice.
Pedersen TX; Binder CJ; Fredrikson GN; Nilsson J; Bro S; Nielsen LB
Nephrol Dial Transplant; 2010 Aug; 25(8):2486-91. PubMed ID: 20164045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
